Literature DB >> 9737991

Purification and characterization of a polysome-associated endoribonuclease that degrades c-myc mRNA in vitro.

C H Lee1, P Leeds, J Ross.   

Abstract

The regulation of mRNA half-lives is determined by multiple factors, including the activity of the messenger RNases (mRNases) responsible for destroying mRNA molecules. Previously, we used cell-free mRNA decay assays to identify a polysome-associated endonuclease that cleaves c-myc mRNA within the coding region. A similar activity has been solubilized and partially purified from a high salt extract of adult rat liver polysomes. Based on a correlation between protein and enzyme activity, the endonuclease is tentatively identified as a approximately 39-kDa protein. It cleaves the coding region stability determinant of c-myc mRNA with considerable specificity. Cleavages occur predominantly in an A-rich segment of the RNA. The endonuclease is resistant to RNase A inhibitors, sensitive to vanadyl ribonucleoside complex, and dependent on magnesium. In these and other respects, the soluble enzyme we have purified resembles the polysome-associated c-myc mRNase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737991     DOI: 10.1074/jbc.273.39.25261

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Identification of in vivo mRNA decay intermediates corresponding to sites of in vitro cleavage by polysomal ribonuclease 1.

Authors:  M N Hanson; D R Schoenberg
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

2.  Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1.

Authors:  K S Cunningham; R E Dodson; M A Nagel; D J Shapiro; D R Schoenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

4.  The poly(A)-binding protein and an mRNA stability protein jointly regulate an endoribonuclease activity.

Authors:  Z Wang; M Kiledjian
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  An endonuclease activity similar to Xenopus PMR1 catalyzes the degradation of normal and nonsense-containing human beta-globin mRNA in erythroid cells.

Authors:  Kirsten A Bremer; Audrey Stevens; Daniel R Schoenberg
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

Review 6.  Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism.

Authors:  Rafal Tomecki; Andrzej Dziembowski
Journal:  RNA       Date:  2010-07-30       Impact factor: 4.942

7.  Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment.

Authors:  M Stoneley; T Subkhankulova; J P Le Quesne; M J Coldwell; C L Jopling; G J Belsham; A E Willis
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

8.  Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization.

Authors:  H Tourrière; I E Gallouzi; K Chebli; J P Capony; J Mouaikel; P van der Geer; J Tazi
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Beta -Globin mRNA decay in erythroid cells: UG site-preferred endonucleolytic cleavage that is augmented by a premature termination codon.

Authors:  Audrey Stevens; Yang Wang; Kirsten Bremer; Jing Zhang; Robert Hoepfner; Michael Antoniou; Daniel R Schoenberg; Lynne E Maquat
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.